Status:
NOT_YET_RECRUITING
Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions
Lead Sponsor:
Changhai Hospital
Collaborating Sponsors:
The First Affiliated Hospital of Dalian Medical University
The Second Hospital of Hebei Medical University
Conditions:
Adenoma
Sessile Serrated Adenoma
Eligibility:
All Genders
45-85 years
Phase:
NA
Brief Summary
Texture and Color Enhancement Imaging (TXI) is a newly developed image-enhancing endoscopy technology that has show potential in improving detection of colorectal lesions. This multicenter, randomized...
Eligibility Criteria
Inclusion
- patients aged 45-85 years and scheduled for screening colonoscopy who provided written informed consent
Exclusion
- Surveillance, diagnostic or therapeutic colonoscopy
- Patients with an already known or suspected colorectal tumour
- Patients with alarming symptoms and signs, including haematochezia, melena, weight loss or anaemia without specific causes, an abdominal mass and positive digital rectal examination
- Pregnant or lactating women
- Patients with gastrointestinal tract obstruction
- Patients with inflammatory bowel diseases, hereditary CRC syndromes or serrated polyposis syndrome
- Patients with abnormal blood coagulation or taking antiplatelets or anticoagulants within 7 days before colonoscopy
- Patients with failed cecal intubation
- Patients with poor bowel preparation quality that necessitated a second bowel preparation
- Patients with a history of colonic resection
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
2964 Patients enrolled
Trial Details
Trial ID
NCT06515977
Start Date
August 1 2024
End Date
August 1 2025
Last Update
July 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.